History Made: Australia Bans Genetic Discrimination in Life Insurance

The fear of ‘financial toxicity’ will no longer stand between Australians and life-saving health information. In a landmark victory for public health, the Senate has passed legislation banning life insurers from using adverse genetic test results to deny or hike the cost of cover.

For over a decade, many Australians have faced a devastating choice: financial security or their health. Despite the availability of genetic testing that could identify a high risk of breast cancer or other hereditary conditions, individuals have frequently avoided or delayed testing. The reason was not a lack of desire for answers, but a well-founded fear that those answers would be used against them by insurance companies.

With this new legislation passed by the Albanese Government, that barrier has finally been dismantled.

A decade of advocacy

This reform is a testament to the persistent advocacy of Dr. Jane Tiller and her team at Monash University. For ten years, Dr. Tiller has led the charge, providing the rigorous research and stakeholder insights necessary to inform this legislative milestone along with an alliance of stakeholders and advocates who supported the journey towards this successful legislation.

Breast Cancer Network Australia (BCNA) is immensely excited and humbled to have been involved in this work. Contributing to an advocacy effort that will fundamentally change the landscape of preventive medicine in Australia has been a significant honour for our organisation.

“It is just extraordinary to be here after almost a decade of advocacy, with an actual piece of legislation that will protect everyday Australians,” Dr. Tiller said. “This law will give people the safety to have genetic testing without worrying about the possible implications for their life insurance.”

Moving toward preventive medicine

The ban is more than just an insurance reform; it is a catalyst for the future of genomic medicine in Australia. Dr. Tiller, who co-leads the DNA Screen program, notes that this legislation paves the way for government investment in preventive genomic screening for all adults.

Currently, around 9 in 10 Australians at high genetic risk remain undetected because of strict eligibility criteria for publicly funded testing. DNA Screen pilot programs have found that approximately one in 50 young Australians carries a high-risk genetic variant for conditions like breast and ovarian cancer, Lynch syndrome, or familial hypercholesterolaemia.

Vicki Durston, BCNA Director of Policy, Advocacy and Support Services, describes the legislation as a landmark victory.

Preventive genomic screening is critical if we are to move into an era of preventive medicine,” Durston said. “We welcome the government’s action and join the call to expand DNA Screen to help prevent breast cancer and other diseases.”

A win for public health

Dozens of Federal parliamentarians spoke in support of the bill, highlighting the incredible level of political will towards this policy change. Dr. Mike Freelander MP, a paediatrician who championed the bill, described it as “one of the most important pieces of legislation to pass through this parliament.”

BCNA extends its warmest congratulations to Dr. Jane Tiller and the Monash University team and all advocates who supported the journey towards this successful legislation. Their tireless leadership has ensured that scientific advances will now benefit every Australian, regardless of their genetic makeup.